drugset / Trial / NCT01265563

N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy

NCT01265563

RandomizedParallel-groupTriple-blindTreatment

Summary

The study is done to find out whether the combined use of the nutritional supplements N-acetylcysteine and Siliphos (milk thistle extract) corrects the shedding of urine protein and oxidative damage (damage to cells and organs often compared to fast aging) in patients with Type 2 Diabetes Mellitus (T2DM) and diabetic kidney disease.

Timeline

Start
2011-01
Primary completion
2015-02
Completion
2016-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 600 mg Oral
Subject Silymarin Traditional medicine (herbal / TCM) 480 mg Oral
Subject Silymarin Traditional medicine (herbal / TCM) 960 mg Oral